Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2020-04-09
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to assess the safety and tolerability and to determine the
recommended phase 2 dose of S 95005 given in combination with oxaliplatin in patients with
metastatic colorectal cancer.